Please assess the completion status of the following clinical trial:

Trial Title: Cryoanesthesia for Intravitreal Injections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Bilateral macular disease due to either exudative macular degeneration or diabetic retinopathy requiring bilateral intravitreal injections~* Have had at least one prior intravitreal injection~* Able to give informed consent~Exclusion Criteria:~* Unilateral disease~* Unable to provide consent~* Preexisting conjunctival, episcleral or scleral defects or disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Cryoanesthesia Device -5 degrees Celsius for 10 seconds (Type: EXPERIMENTAL): All patients will have one eye randomized to receiving anesthesia via the cryoanesthesia device which anesthetizes by chilling rather than by use of drug, prior to receiving an intravitreal injection.~Comment: Cryoanesthesia Device is the name of the device.
- Cryoanesthesia Device -5 degrees Celsius for 20 seconds (Type: EXPERIMENTAL): All patients will have one eye randomized to receiving anesthesia via the cryoanesthesia device which anesthetizes by chilling rather than by use of drug, prior to receiving an intravitreal injection.~Comment: Cryoanesthesia Device is the name of the device.
- Cryoanesthesia Device -7 degrees Celsius for 20 seconds (Type: EXPERIMENTAL): All patients will have one eye randomized to receiving anesthesia via the cryoanesthesia device which anesthetizes by chilling rather than by use of drug, prior to receiving an intravitreal injection.~Comment: Cryoanesthesia Device is the name of the device.
- Cryoanesthesia Device -10 degrees Celsius for 10 seconds (Type: EXPERIMENTAL): All patients will have one eye randomized to receiving anesthesia via the cryoanesthesia device which anesthetizes by chilling rather than by use of drug, prior to receiving an intravitreal injection.~Comment: Cryoanesthesia Device is the name of the device.
- Cryoanesthesia Device -10 degrees Celsius for 20 seconds (Type: EXPERIMENTAL): All patients will have one eye randomized to receiving anesthesia via the cryoanesthesia device which anesthetizes by chilling rather than by use of drug, prior to receiving an intravitreal injection.~Comment: Cryoanesthesia Device is the name of the device.
- Lidocaine (Type: ACTIVE_COMPARATOR): Participants randomized to this arm will have their other eye receive anesthesia via the current standard of care treatment method (lidocaine) prior to receiving an intravitreal injection.~Lidocaine: Lidocaine will be applied to the non-cryoanesthesia eye.

Based on this trial design, predict the completion outcome and termination type (if applicable).